Benign · Pigmented mimicSK variantMelanoma mimic

Melanoacanthoma

Cutaneous melanoacanthoma; pigmented seborrhoeic keratosis variant; melanoacanthoma of Mishima and Pinkus; oral melanoacanthoma when mucosal/reactive

Melanoacanthoma is a benign epithelial lesion best regarded in cutaneous practice as a heavily pigmented variant within the seborrhoeic keratosis spectrum, with proliferation of both keratinocytes and dendritic melanocytes. Its importance is diagnostic rather than biological: it may be very dark, irregular, verrucous or rapidly noticed by the patient, so it can look like melanoma, pigmented BCC, pigmented Bowen disease or a traumatised seborrhoeic keratosis. If the diagnosis is not secure clinically and dermoscopically, biopsy or removal for histology is appropriate.

CurrentLast reviewed 5 June 2026

Clinical recognition

  • Usually presents as a solitary, sharply circumscribed, dark brown to black papule, plaque or verrucous nodule.
  • Most cutaneous lesions occur on trunk, head and neck or extremities in adults, often with the clinical feel of a seborrhoeic keratosis.
  • Surface may be waxy, stuck-on, papillomatous, crusted or irritated.
  • Rapid apparent change may reflect inflammation, trauma or new clinical recognition, but melanoma must be excluded if features are atypical.
  • Oral melanoacanthoma is a separate reactive mucosal melanocytic proliferation, typically on buccal mucosa, and should not be managed as an ordinary cutaneous SK.

Dermoscopy

  • May show seborrhoeic-keratosis clues such as milia-like cysts, comedo-like openings, fissures/ridges and a sharply demarcated edge.
  • Heavy melanin can obscure classic SK structures and create a melanoma-like black, blue-black or variegated pattern.
  • Irritated lesions may show crust, haemorrhage and polymorphous vascularity.
  • Absence of reassuring SK features, asymmetry, atypical network, blue-white veil, irregular dots/globules or atypical vessels should prompt biopsy.
  • Do not rely on the label “melanoacanthoma” clinically unless histology or very secure dermoscopic features support it.

Histology

  • Acanthotic epithelial proliferation resembling seborrhoeic keratosis with increased dendritic melanocytes scattered through the lesion.
  • Pigment is often abundant within keratinocytes, melanocytes and melanophages.
  • There should be no invasive malignant melanocytic proliferation; immunohistochemistry can highlight the dendritic melanocyte population if needed.
  • Histology separates melanoacanthoma from melanoma, pigmented Bowen disease, pigmented BCC and collision tumours.
  • Clinicopathological correlation is important when a biopsy samples only part of a heterogeneous pigmented lesion.

Management

  • If clinically typical and dermoscopically secure as a seborrhoeic keratosis variant, reassurance is appropriate.
  • If there is any melanoma concern, perform biopsy/excision rather than destructive treatment.
  • Shave excision, curettage or elliptical excision can be used depending on site, thickness and diagnostic need.
  • Once histologically confirmed, no oncological follow-up is required for a completely treated cutaneous melanoacanthoma.
  • For oral pigmented lesions, refer to oral medicine/maxillofacial or appropriate mucosal pathway if diagnosis is uncertain.

Key differentials

  • Melanoma, including nodular melanoma and melanoma arising near seborrhoeic keratosis.
  • Pigmented basal cell carcinoma and pigmented Bowen disease/SCC in situ.
  • Irritated seborrhoeic keratosis, dermatosis papulosa nigra and pigmented verruca.
  • Pigmented actinic keratosis or lichen planus-like keratosis.
  • Collision tumour: a benign SK-like lesion adjacent to or overlying a malignant tumour.

References

  1. StatPearls / NCBI Bookshelf. Cutaneous melanoacanthoma.
  2. DermNet. Seborrhoeic keratosis.
  3. Mishima Y, Pinkus H. Benign mixed tumour of melanocytes and malpighian cells: melanoacanthoma. Arch Dermatol. 1960;81:539-550.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.